Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01915225 · ClinicalTrials.gov registry record
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
A clinical trial of Cholangiocarcinoma and Colorectal Neoplasms, sponsored by National Cancer Institute (NCI).
- Recruiting
- Registry status
- 1,800
- Enrollment target
- 1
- Study location
NCT01915225 is a study of Cholangiocarcinoma and Colorectal Neoplasms that is actively recruiting participants, run by National Cancer Institute (NCI). The registered enrollment target is 1,800 participants, above the 356-participant average among 60 other Cholangiocarcinoma trials with a reported enrollment target (406% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01915225, a study of Cholangiocarcinoma and Colorectal Neoplasms, is actively recruiting participants, sponsored by National Cancer Institute (NCI).
- RECRUITING
- Registry status
- 1,800 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: \- Recent advances in cancer research have led to new therapies to treat the disease. It is important to continue these advances and discover new ones. To do that, researchers need tissue samples from solid tumors. This study will collect such samples from people already scheduled to have a procedure at the National Institutes of Health Clinical Center (NIHCC). Objectives: \- To collect tissue samples for use in studying new ways to treat tumors. Eligibility: * Adults 18 years and older, with a precancerous or cancerous solid tumor who are scheduled to have surgery or a biopsy at the NIHCC. * Children under the age of 18 but who are older than 2 years of age are eligible to be enrolled on the research sample collection portion of this study if they will have a biopsy or surgery as part of their medical care. Design: * Before their procedure, participants will have a small blood sample taken. * Some participants will undergo leukapheresis. In this procedure, blood is removed through a tube in one arm and circulated through a machine that removes white blood cells. The blood, minus the white blood cells, is returned through a tube in the other arm. The procedure takes 3-4 hours. * For all participants, during the surgery or biopsy, pieces of the tumor and pieces of normal tissue near it will be removed for this study. The rest of the tumor or precancerous growth will be sent to a lab for analysis. * Participants will return to the clinic about 6 weeks after the operation for a routine checkup. Some may have to return for additional follow-up.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,800 participants |
| Start Date | 2013-07-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01915225
The ClinicalTrials.gov registry entry for NCT01915225 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,800 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 356-participant average among 60 other Cholangiocarcinoma trials with a reported enrollment target (406% higher). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Cholangiocarcinoma appearing as the primary indexed condition, and to 0 interventions.
NCT01915225 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT01915225 about?
NCT01915225 is a clinical study titled "Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer". Background: \- Recent advances in cancer research have led to new therapies to treat the disease. It is important to continue these advances and discover new ones. To do that, researchers need tissue samples from solid tumors. This study will collect such samples from people already scheduled to ha...
What is the current status of trial NCT01915225?
This trial is currently recruiting. The enrollment target is 1,800 participants. The study started on 2013-07-21.
What conditions does trial NCT01915225 study?
This clinical trial studies the following conditions: Cholangiocarcinoma, Colorectal Neoplasms, Pancreas Cancer, Bile Duct Cancer, Gastric Neoplasms.
Who is sponsoring clinical trial NCT01915225?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01915225 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cholangiocarcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)
RECRUITING · Phase 2
-
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
RECRUITING · Phase 4
-
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
RECRUITING · Phase 2
-
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
RECRUITING · Phase 1
-
Targeted Navigation in Hepatocellular Carcinoma (HCC)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.